Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo

Cancer Letters

Volumn 308, Issue 2, 2011, Pages 144-151

  Chen, Jian ^a   Liu, Litao ^a   Hou, Ruanling ^b   Shao, Zhenjun ^a   Wu, Yiying ^a   Chen, Xiajing ^a   Zhou, Liming ^a  

^a SICHUAN UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Calycosin; ERK1 2; OVX

Indexed keywords

CALYCOSIN; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR STRUCTURE;

MUS;

EID: 79959547289     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.04.022     Document Type: Article

References (29)

1. Chen W.F., Wong M.S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab. 2004, 89:2351-2359.
2. Bitto A., Polito F., Squadrito F., Marini H., D'Anna R., Irrera N., Minutoli L., Granese R., Altavilla D. Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation. Curr. Med. Chem. 2010, 17:3007-3018.
3. Pilšáková L., Riečanský I., Jagla F. The physiological actions of isoflavone phytoestrogens. Physiol. Res. 2010, 59:651-664.
4. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998, 58:3833-3838.
5. Messina M.J., Loprinzi C.L. Soy for breast cancer survivors: a critical review of the literature. J. Nutr. 2001, 131:3095S-3108S.
6. Clinton D.A., Kimberly F.A., Young H.J., Tracy S.G., Daniel R.D., William G.H. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004, 25:1649-1657.
7. Gao Q., Li J., Cheung J.K., Duan J., Ding A., Cheung A.W., Zhao K., Li W.Z., Dong T.T., Tsim K.W. Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae. Chin. Med. 2007, 29:2-12.
8. Song Z.H., Ji Z.N., Lo C.K., Dong T.T., Zhao K.J., Li O.T., Haines C.J., Kung S.D., Tsim K.W. Chemical and biological assessment of a traditional chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis: orthogonal array design to optimize the extraction of chemical constituents. Planta Med. 2004, 70:1222-1227.
9. Choi R.C., Gao Q.T., Cheung A.W., Zhu J.T., Lau F.T., Li J., Li W.Z., Chu G.K., Duan R., Cheung J.K., Ding A.W., Zhao K.J., Dong T.T., Tsim K.W. A Chinese herbal decoction, Danggui Buxue Tang, stimulates proliferation, differentiation and gene expression of cultured osteosarcoma cells: genomic approach to reveal specific gene, activation. Evid. Based Complement Alternat. Med. 2009, (January 8).
10. Yu Q.T., Qi L.W., Li P., Yi L., Zhao J., Bi Z. Determination of seventeen main flavonoids and saponins in the medicinal plant Huang-qi (Radix astragali) by HPLC-DAD-ELSD. J. Sep. Sci. 2007, 30:292-1299.
11. Yu D., Duan Y., Bao Y., Wei C., An L. Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by l-glutamate. J. Ethnopharmacol. 2005, 98:89-94.
12. Zhu H., Zhang Y., Ye G., Li Z., Zhou P., Huang C. In vivo and in vitro antiviral activities of calycosin-7-O-beta-d-glucopyranoside against coxsackie virus B3. Biol. Pharm. Bull. 2009, 32:68-73.
13. Yu D.H., Bao Y.M., An L.J., Yang M. Protection of PC12 cells against superoxide-induced damage by isoflavonoids from Astragalus mongholicus. Biomed. Environ. Sci. 2009, 50-54.
14. Tang J.Y., Li S., Li Z.H., Zhang Z.J., Hu G., Cheang L.C., Alex D., Hoi M.P., Kwan Y.W., Chan S.W., Leung G.P., Lee S.M. Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC. PLoS One 2010, 5:e11822.
15. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
16. Kim K.H., Moriarty K., Bender J.R. Vascular cell signaling by membrane estrogen receptors. Steroids 2008, 73:864-869.
17. Kim-Schulze S., McGowan K.A., Hubchak S.C., Cid M.C., Martin M.B., Kleinman H.K., Greene G.L., Schnaper H.W. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996, 94:1402-1407.
18. Doshida M., Ohmichi M., Tsutsumi S., Kawagoe J., Takahashi T., Du B., Mori-Abe A., Ohta T., Saitoh-Sekiguchi M., Takahashi K., Kurachi H. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells. J. Biol. Chem. 2006, 281:24270-24278.
19. Morales D.E., McGowan K.A., Grant D.S., Maheshwari S., Bhartiya D., Cid M.C., Kleinman H.K., Schnaper H.W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763.
20. Maggiolini M., Bonofiglio D., Marsico S., Panno M.L., Cenni B., Picard D., Andò S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 2001, 60:595-602.
21. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 1986, 83:2496-2500.
22. Driggers P.H., Segars J.H. Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol. Metab. 2002, 13:422-427.
23. Segars J.H., Driggers P.H. Estrogen action and cytoplasmic signaling cascades. Part I: Membrane-associated signaling complexes. Trends Endocrinol. Metab. 2002, 13:349-354.
24. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 2005, 19:1951-1959.
25. Di X., Yu L., Moore A.B., Castro L., Zheng X., Hermon T., Dixon D. A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. Hum. Reprod. 2008, 23:1873-1883.
26. Schaeffer H., Weber M. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 1999, 19:2435-2444.
27. Campbell J., Sege R., Graves J., Graves L., Jensen A., Krebs E. The MAP kinase cascade. Recent Prog. Horm. Res. 1995, 50:131-159.
28. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
29. Pagès G., Milanini J., Richard D.E., Berra E., Gothié E., Viñals F., Pouysségur J. Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann. N.Y. Acad. Sci. 2000, 902:187-200.